\u00dcniversite Cincinnati Kanser Merkezi ara\u015ft\u0131rmac\u0131lar\u0131, Chicago\u2019da d\u00fczenlenecek olan 2025 Amerikan Kanser Ara\u015ft\u0131rmalar\u0131 Derne\u011fi (AACR) Y\u0131ll\u0131k Toplant\u0131s\u0131\u2019nda kanser ara\u015ft\u0131rmalar\u0131na ili\u015fkin pek \u00e7ok \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bulguyu payla\u015fmaya haz\u0131rlan\u0131yor. \u00d6zellikle ba\u015f ve boyun kanseri (HNC) ile ilgili y\u00fcr\u00fct\u00fclen \u00e7al\u0131\u015fmalar, karma\u015f\u0131k molek\u00fcler mekanizmalar, ba\u011f\u0131\u015f\u0131kl\u0131k sistemi etkile\u015fimleri ve yenilik\u00e7i tedavi yakla\u015f\u0131mlar\u0131n\u0131 kapsamaktad\u0131r. Bu ara\u015ft\u0131rmalar, kanser tedavisinde paradigmay\u0131 d\u00f6n\u00fc\u015ft\u00fcrme potansiyeline sahip olup, ki\u015fiye \u00f6zg\u00fc onkoloji alan\u0131nda \u00f6nemli ilerlemeleri temsil ediyor.<\/p>\n
Ba\u015f ve boyun skuam\u00f6z h\u00fccreli karsinomu (HNSCC) \u00fczerine odaklanan bir \u00e7al\u0131\u015fma, interl\u00f6kin-9\u2019un (IL-9) bu hastalardaki rol\u00fcn\u00fc ilk kez netle\u015ftiriyor. IL-9, \u00f6nceden kanser t\u00fcr\u00fcne g\u00f6re hem t\u00fcm\u00f6r b\u00fcy\u00fcmesini h\u0131zland\u0131r\u0131c\u0131 hem de engelleyici etkiler g\u00f6steren k\u00fc\u00e7\u00fck bir protein olarak bilinmektedir. Sam Nusbaum liderli\u011findeki ara\u015ft\u0131rma, HNSCC hastalar\u0131ndan al\u0131nan t\u00fcm\u00f6r dokular\u0131nda IL-9 ifadesinin sa\u011fl\u0131kl\u0131 bireylere k\u0131yasla anlaml\u0131 \u015fekilde artt\u0131\u011f\u0131n\u0131 ortaya koydu. Daha y\u00fcksek IL-9 mRNA seviyelerinin hasta sa\u011fkal\u0131m\u0131 ile olumsuz korelasyon g\u00f6sterdi\u011fi, dolay\u0131s\u0131yla IL-9\u2019un prognostik bir biyobelirte\u00e7 olabilece\u011fi belirlendi. H\u00fccresel d\u00fczeyde IL-9\u2019un, kanser h\u00fccrelerini yok etmekle g\u00f6revli sitotoksik ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin fonksiyonunu bozan IL-6 salg\u0131s\u0131n\u0131 tetikledi\u011fi g\u00f6r\u00fcld\u00fc.<\/p>\n
Ancak IL-9\u2019un kanser \u00fczerindeki etkileri tek tarafl\u0131 de\u011fil. Hayvan modellerinde, IL-9 art\u0131\u015f\u0131n\u0131n t\u00fcm\u00f6r hacmi ve a\u011f\u0131rl\u0131\u011f\u0131nda azalma ile ili\u015fkilendirildi\u011fi g\u00f6zlendi. Bu durum, IL-9\u2019un ba\u011f\u0131\u015f\u0131kl\u0131k tepkileri \u00fczerindeki kar\u015f\u0131t etkilerini ve t\u00fcm\u00f6r mikro \u00e7evresindeki karma\u015f\u0131k etkile\u015fimler sonucu de\u011fi\u015fken fonksiyonlar\u0131n\u0131 i\u015faret ediyor. Nusbaum ve ekibi, IL-9\u2019un t\u00fcm\u00f6r geli\u015fimi ve ba\u011f\u0131\u015f\u0131kl\u0131k d\u00fczenlemesindeki \u00e7ift y\u00f6nl\u00fc rol\u00fcn\u00fc daha derinlemesine molek\u00fcler d\u00fczeyde \u00e7\u00f6z\u00fcmlemeyi planl\u0131yor.<\/p>\n
Bu molek\u00fcler ke\u015fiflere paralel olarak, Lindsey Bachmann do\u011fal \u00f6ld\u00fcr\u00fcc\u00fc (NK) h\u00fccrelerin i\u015flevini y\u00f6neten sinyal yollar\u0131n\u0131 ara\u015ft\u0131r\u0131yor. NK h\u00fccreleri, kanser h\u00fccrelerini tan\u0131mada ve yok etmede kritik rol oynayan ba\u011f\u0131\u015f\u0131kl\u0131k elemanlar\u0131d\u0131r. Ara\u015ft\u0131rma, CXCR2 resept\u00f6r\u00fcn\u00fcn engellenmesinin, NK h\u00fccreleri ve CD8+ T lenfositlerinin varl\u0131\u011f\u0131nda fare modellerinde t\u00fcm\u00f6r b\u00fcy\u00fcmesini engelledi\u011fini ortaya koydu. CXCR2, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin t\u00fcm\u00f6r i\u00e7indeki hareketini ve aktivasyonunu kontrol eden bir kemokin resept\u00f6r\u00fcd\u00fcr. Bu bulgu, CXCR2 hedeflenerek ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131n\u0131n g\u00fc\u00e7lendirilmesi yoluyla yeni imm\u00fcnoterapi stratejilerinin geli\u015ftirilmesine olanak sa\u011flayabilir.<\/p>\n
Tan\u0131sal y\u00f6ntemlerde yenilik\u00e7i \u00e7al\u0131\u015fmalar da kanser tedavisinin izlenmesinde devrim yaratma potansiyeline sahip. Katelyn Jansen liderli\u011findeki ekip, periferik kan monon\u00fckleer h\u00fccrelerinin (PBMC) hasta kan \u00f6rneklerinden izolasyonunda standart protokoller geli\u015ftirdi\u011fini duyurdu. \u00d6nemli olarak, kan \u00f6rneklerinin 24 saate kadar gecikmeli i\u015flenmesi h\u00fccre canl\u0131l\u0131\u011f\u0131n\u0131 olumsuz etkilemedi. Bu metodolojik yenilik, imm\u00fcnoterapi yan\u0131tlar\u0131n\u0131n non-invaziv \u015fekilde, daha g\u00fcvenilir ve s\u0131k takip edilmesini m\u00fcmk\u00fcn k\u0131larak klinik uygulamalarda \u00f6nemli kolayl\u0131klar sa\u011flayabilir. Ara\u015ft\u0131rma, protokollerin ba\u015fka merkezlerde validasyonu ve PBMC analizlerinin klasik biyopsi verileriyle kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131 s\u00fcrecine devam ediyor.<\/p>\n
Jansen ve ekibi, ayn\u0131 zamanda tekrar eden ba\u015f ve boyun kanserlerinde imm\u00fcnoterapi ile radyasyon tedavisinin kombine kullan\u0131m\u0131n\u0131 da inceledi. Proton terapisi (PT) ve konvansiyonel X-\u0131\u015f\u0131n\u0131 radyoterapisinin (XRT), tek ba\u015f\u0131na t\u00fcm\u00f6r b\u00fcy\u00fcmesini bask\u0131lad\u0131\u011f\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccre infiltrasyonunu art\u0131rd\u0131\u011f\u0131 g\u00f6r\u00fcld\u00fc. Ancak, bu radyasyon t\u00fcrlerine anti-PD1 imm\u00fcn kontrol noktas\u0131 inhibit\u00f6rlerinin eklenmesi ek bir sinerjik etki yaratmada s\u0131n\u0131rl\u0131 kald\u0131. Bu da, hidrasyon a\u015famas\u0131nda radyasyonun imm\u00fcn mikro\u00e7evreyi haz\u0131rlamas\u0131na ra\u011fmen, imm\u00fcnoterapinin beklenen t\u00fcm\u00f6r bask\u0131lay\u0131c\u0131 etkisini art\u0131rmada hen\u00fcz istenilen seviyeye ula\u015f\u0131lamad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Gelecekte \u00e7al\u0131\u015fmalar, dozlama programlar\u0131n\u0131n ve yeni ba\u011f\u0131\u015f\u0131kl\u0131k mod\u00fclat\u00f6rlerinin optimizasyonuna odaklanacak.<\/p>\n
Meme kanserinde ise, \u00f6zellikle HER2 pozitif t\u00fcm\u00f6rler \u00fczerine yo\u011funla\u015fan ara\u015ft\u0131rma, nonkas iskelet miyozin IIA\u2019n\u0131n (NMIIA) rol\u00fcn\u00fc a\u00e7\u0131\u011fa \u00e7\u0131kard\u0131. Bu agresif meme kanseri t\u00fcr\u00fcnde HER2 proteini fazladan bulunur ve t\u00fcm\u00f6r h\u0131zl\u0131 b\u00fcy\u00fcr, metastaz yapar. Ara\u015ft\u0131rma NMIIA\u2019n\u0131n HER3 resept\u00f6r\u00fcyle etkile\u015fim kurarak ila\u00e7 direncine ve metastatik s\u00fcrece arac\u0131l\u0131k eden h\u00fccre i\u00e7i sinyal yollar\u0131n\u0131 d\u00fczenledi\u011fini g\u00f6sterdi. Klinik veriler, \u00f6zellikle lenfovask\u00fcler invazyon (LVI)-pozitif t\u00fcm\u00f6rlerde y\u00fcksek NMIIA seviyelerinin k\u00f6t\u00fc hasta sa\u011fkal\u0131m\u0131yla ili\u015fkilendirildi\u011fini ortaya koydu. Ara\u015ft\u0131rma ekibi, NMIIA\u2019y\u0131 hedef alan yeni bir inhibit\u00f6r geli\u015ftiriyor. Bu ilac\u0131n, HER2 hedefli tedavilerle birlikte kullan\u0131lmas\u0131, ila\u00e7 direnci ve metastazla m\u00fccadelede \u00f6nemli bir yenilik olabilir.<\/p>\n
Nadir bir akci\u011fer hastal\u0131\u011f\u0131 olan lenfangioleiomyomiyomatozis (LAM) alan\u0131ndaki \u00e7al\u0131\u015fmalar ise metabolik a\u00e7\u0131dan dikkat \u00e7ekici bulgular sunuyor. Ara\u015ft\u0131rman\u0131n ba\u015f yazar\u0131 Evans Abor, LAM progresyonunda kritik rol oynayan PHGDH enzimini ve onun mTORC1 sinyal sistemi ile etkile\u015fimini inceledi. PHGDH\u2019nin hastal\u0131kl\u0131 dokularda anlaml\u0131 bi\u00e7imde artt\u0131\u011f\u0131 ve bu enzim inhibe edildi\u011finde LAM h\u00fccrelerinde apoptozun tetiklendi\u011fi, mitokondriyal i\u015flev ve makromolek\u00fcler biyosentezin bozuldu\u011fu g\u00f6zlendi. Rapamisin ile kombinasyon tedavisi, h\u00fccresel otofajiyi art\u0131rarak terap\u00f6tik sinerji yaratt\u0131. Bu metabolik yakla\u015f\u0131m, tedavi direncini yenmek ve hastal\u0131\u011f\u0131n ilerlemesini engellemek i\u00e7in yeni umutlar sunuyor.<\/p>\n
Ayr\u0131ca Kanser Merkezi\u2019nin ara\u015ft\u0131rmalar\u0131 kolorektal kanser alan\u0131nda HER aile resept\u00f6rleri ile mutant KRAS\u2019\u0131 hedef alman\u0131n etkinli\u011fi ve tuberin eksikli\u011fi olan h\u00fccrelerde Stat1 sinyalinin t\u00fcm\u00f6r imm\u00fcnyetkisindeki rol\u00fc gibi farkl\u0131 konular\u0131 da i\u00e7eriyor. Tuberin eksikli\u011fi, LAM patolojisi ile ba\u011flant\u0131l\u0131d\u0131r. Bu \u00e7ok y\u00f6nl\u00fc yakla\u015f\u0131mlar, kanser ve nadir hastal\u0131klara adanm\u0131\u015f kapsaml\u0131 bilimsel \u00e7al\u0131\u015fman\u0131n bir g\u00f6stergesi olarak dikkat \u00e7ekmektedir.<\/p>\n
Toplanan bu zengin veriler, molek\u00fcler ayr\u0131nt\u0131larla ki\u015fiselle\u015ftirilmi\u015f onkoloji \u00e7a\u011f\u0131na g\u00fc\u00e7l\u00fc bir giri\u015f yap\u0131ld\u0131\u011f\u0131n\u0131 g\u00f6steriyor. \u0130mm\u00fcnoloji, molek\u00fcler biyoloji ve translasyonel t\u0131bb\u0131n kesi\u015fimi, hasta odakl\u0131, hedeflenmi\u015f tedaviler, minimal invaziv tan\u0131 y\u00f6ntemleri ve t\u00fcm\u00f6r direncini a\u015fan kombinasyon terapileri gibi yenilik\u00e7i \u00e7\u00f6z\u00fcmlere kap\u0131 aral\u0131yor. AACR 2025 toplant\u0131s\u0131nda \u00dcniversite Cincinnati Kanser Merkezi\u2019nin sunaca\u011f\u0131 ara\u015ft\u0131rmalar, klinik onkoloji alan\u0131nda yeni i\u015f birliklerini tetikleyerek kanser bak\u0131m standartlar\u0131n\u0131n yak\u0131n gelecekte evriminde etkili olacak.<\/p>\n
Bu kapsamda, temel bilimsel bulgular ile uygulamal\u0131 ara\u015ft\u0131rmalar\u0131 harmanlayan bu teklifler, onkolojinin en b\u00fcy\u00fck zorluklar\u0131na yarat\u0131c\u0131 yan\u0131tlar arayan bilim insanlar\u0131n\u0131n dinamik \u00e7abas\u0131n\u0131n \u00f6rnekleri olarak \u00f6ne \u00e7\u0131k\u0131yor. Kanser tedavisinde, molek\u00fcler hedefleme stratejilerinin ve ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin anla\u015f\u0131lmas\u0131 temelinde, hastalar\u0131n hayat kalitesini art\u0131racak ve ya\u015fam s\u00fcrelerini uzatacak yeni nesil tedavi se\u00e7enekleri geli\u015ftirme y\u00f6n\u00fcnde \u00f6nemli ad\u0131mlar at\u0131lmaktad\u0131r.<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Ba\u015f ve boyun kanseri, meme kanseri, lenfangioleiomyomiyomatozis, kanser imm\u00fcnoterapisi, nadir hastal\u0131klarda metabolik zafiyetler \u00dcniversite Cincinnati Kanser Merkezi ara\u015ft\u0131rmac\u0131lar\u0131, Chicago\u2019da d\u00fczenlenecek olan 2025 Amerikan Kanser Ara\u015ft\u0131rmalar\u0131 Derne\u011fi (AACR) Y\u0131ll\u0131k Toplant\u0131s\u0131\u2019nda kanser ara\u015ft\u0131rmalar\u0131na ili\u015fkin pek \u00e7ok \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bulguyu payla\u015fmaya haz\u0131rlan\u0131yor. \u00d6zellikle ba\u015f ve boyun kanseri (HNC) ile ilgili y\u00fcr\u00fct\u00fclen \u00e7al\u0131\u015fmalar, karma\u015f\u0131k molek\u00fcler mekanizmalar, ba\u011f\u0131\u015f\u0131kl\u0131k sistemi etkile\u015fimleri ve yenilik\u00e7i tedavi yakla\u015f\u0131mlar\u0131n\u0131 kapsamaktad\u0131r. Bu ara\u015ft\u0131rmalar, kanser tedavisinde paradigmay\u0131 d\u00f6n\u00fc\u015ft\u00fcrme potansiyeline sahip…<\/p>\n","protected":false},"author":1,"featured_media":3924,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[3337,3339,3340,3338,3336],"tmauthors":[],"class_list":{"0":"post-3923","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-bas-ve-boyun-skuamoz-hucreli-karsinomu-tedavi-yaklasimlari","9":"tag-cxcr2-hedefli-immunoterapi-stratejileri","10":"tag-dogal-oldurucu-hucrelerin-kanser-bagisiklik-rolu","11":"tag-il-9-prognostik-biyobelirtec-calismalari","12":"tag-kanser-arastirmalari-aacr-2025"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/UC-Cancer-Center-AACR-20258217te-Yenilikleri-Paylasti-1745604880.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3923"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3923\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3924"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3923"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMakale Ba\u015fl\u0131\u011f\u0131<\/strong>: University of Cincinnati Cancer Center Unveils Novel Insights at AACR 2025: IL-9\u2019s Paradoxical Role, Immune Signaling Pathways, and Emerging Therapeutic Targets
\nAnahtar Kelimeler<\/strong>: Ba\u015f ve boyun kanseri, meme kanseri, t\u00fcm\u00f6r b\u00fcy\u00fcmesi, kanser imm\u00fcnoterapisi, inhibe edici etkiler, hayvan modelleri, periferik kan monon\u00fckleer h\u00fccreler, radyasyon tedavisi, NK h\u00fccre resept\u00f6r sinyalle\u015fmesi, h\u00fccresel yan\u0131tlar, kanser ara\u015ft\u0131rmalar\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"